Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1990 | 1 |
1991 | 1 |
2012 | 2 |
2013 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Cardiorenal end points in a trial of aliskiren for type 2 diabetes.
N Engl J Med. 2012 Dec 6;367(23):2204-13. doi: 10.1056/NEJMoa1208799. Epub 2012 Nov 3.
N Engl J Med. 2012.
PMID: 23121378
Free article.
Clinical Trial.
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial.
Heller S, Buse J, Fisher M, Garg S, Marre M, Merker L, Renard E, Russell-Jones D, Philotheou A, Francisco AM, Pei H, Bode B; BEGIN Basal-Bolus Type 1 Trial Investigators.
Heller S, et al.
Lancet. 2012 Apr 21;379(9825):1489-97. doi: 10.1016/S0140-6736(12)60204-9.
Lancet. 2012.
PMID: 22521071
Clinical Trial.
Item in Clipboard
Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN(®) Basal-Bolus Type 1): 2-year results of a randomized clinical trial.
Bode BW, Buse JB, Fisher M, Garg SK, Marre M, Merker L, Renard E, Russell-Jones DL, Hansen CT, Rana A, Heller SR; BEGIN® Basal-Bolus Type 1 trial investigators.
Bode BW, et al.
Diabet Med. 2013 Nov;30(11):1293-7. doi: 10.1111/dme.12243. Epub 2013 Jun 17.
Diabet Med. 2013.
PMID: 23710902
Free PMC article.
Clinical Trial.
Item in Clipboard
Human N-acetylation genotype determination with urinary caffeine metabolites.
Kilbane AJ, Silbart LK, Manis M, Beitins IZ, Weber WW.
Kilbane AJ, et al.
Clin Pharmacol Ther. 1990 Apr;47(4):470-7. doi: 10.1038/clpt.1990.59.
Clin Pharmacol Ther. 1990.
PMID: 2328555
Free article.
Item in Clipboard
Kinetics of acetyl CoA: arylamine N-acetyltransferase from rapid and slow acetylator human liver.
Kilbane AJ, Petroff T, Weber WW.
Kilbane AJ, et al.
Drug Metab Dispos. 1991 Mar-Apr;19(2):503-7.
Drug Metab Dispos. 1991.
PMID: 1676662
Item in Clipboard
Cite
Cite